September 17, 2013

Stanton A. Glantz, PhD

Stan Glantz comment submitted to FDA opposing use of third parties to handle tobacco industry research

I just submitted a public comment to the FDA opposing the proposal to have the FDA establish a third party process for handling industry research.  My cover letter said

I wish to submit the attached material, which includes comments I originally posted to my blog (, including the comments submitted by a wide spectrum of academic and other leaders in the tobacco control community, for the FDA’s consideration in evaluating the possible role of independent parties in industry sponsored research.

As detailed in the attached comments, creating such an arrangement is a very bad idea.

Thank you for your consideration.

And I attached the full range of blog comments triggered by Ruth Malone's letter on why she did not go to the FDA's "moderated dialog" with the industry.  You can read the full blog posts here and here.

The deadline for posting comments is September 30, 2013.  I urge everyone to weigh in.

Add new comment

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.